Regulatory Approvals

SPRO: FDA approval, immunology pivot, and $105M financing extend cash runway into 2029

By

Regulatory Approvals — SPRO: FDA approval, immunology pivot, and $105M financing extend cash runway into 2029  TradingView

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. August 12, 2026.

By

Related Post

Regulatory Approvals

What Does the FDA Approval of Orally Disintegrating Nilotinib Tablets Mean for CML Practice?

Regulatory Approvals

FDA Approves Orzeyful (Oveporexton) for Adults With Narcolepsy Type 1

Regulatory Approvals

Replimune finally wins approval, Q2 earnings wrap up, psychedelics stay in spotlight

Financial News For All

Mergers & Acquisitions

Mayer Brown and T&C advise Ecopetrol on acquisition of controlling stake in Brava Energia

Mergers & Acquisitions

Paramount Skydance mulls CNN sale amid antitrust merger challenge

Mergers & Acquisitions

AEVEX to Acquire BlackSea Technologies, Strengthening Its Multi‑Domain Autonomous Systems Capabilities

Mergers & Acquisitions

Attorney General Knudsen urges Surface Transportation Board to deny railroad merger application